Who Buys Terbutaline from India — 131 Importers Behind a $3.5M Market

The importation of Terbutaline from India involves various buyer segments, each with distinct purchasing behaviors:

• Distributors: Entities like PRINCE FARMA, LDA (Angola) and PLANET PHARMA (France) function as intermediaries, procuring large quantities to supply to pharmacies, hospitals, and clinics. Their bulk purchasing often leads to economies of scale, and they typically place regular, sizable orders to maintain a steady supply chain.

• Government Procurement Agencies: Organizations such as the STATE PHARMACEUTICAL CORPORATION OF SRI LANKA are responsible for acquiring medicines for public healthcare facilities. Their procurement is characterized by large-volume purchases through formal tender processes, ensuring consistent supply to meet national healthcare demands.

• Retail Chains and Hospital Groups: While specific entities from the top 10 buyers are not explicitly identified in this category, these buyers usually procure Terbutaline to stock their outlets or facilities, ensuring availability for patients. Their orders are typically based on anticipated patient demand and may vary in volume.

• Re-exporters: Companies like ABACUS PHARMA (AFRICA) LTD, operating in Kenya and Uganda, may act as re-exporters, importing Terbutaline to distribute to neighboring countries. Their purchasing patterns are influenced by regional demand and logistical considerations.

• Contract Manufacturers: Not prominently featured among the top buyers, contract manufacturers would typically procure Terbutaline for formulation into finished pharmaceutical products under contract for other companies. Their orders are project-based and depend on contractual agreements.

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.

For the top five importing countries of Terbutaline from India, the import regulations are as follows:

• Angola:
• Drug Regulatory Authority: Ministry of Health (Ministério da Saúde)
• Import Registration Process: Importers must obtain authorization from the Ministry of Health, ensuring compliance with national pharmaceutical standards.
• Estimated Timeline for Registration: Approximately 3-6 months, depending on the completeness of the application and regulatory reviews.
• Import Tariff/Duty for HS 30049099: Specific tariff rates should be confirmed with the Angolan customs authority, as they are subject to periodic revisions.

• Sri Lanka:
• Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA)
• Import Registration Process: Requires submission of a dossier to the NMRA, including product details, manufacturing information, and evidence of compliance with international standards.
• Estimated Timeline for Registration: Typically 6-12 months, contingent on the review process and any additional information requests.
• Import Tariff/Duty for HS 30049099: Pharmaceuticals may be subject to import duties; exact rates should be verified with Sri Lankan customs authorities.

• France:
• Drug Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM)
• Import Registration Process: Medicines must be authorized by the ANSM, requiring comprehensive documentation and adherence to EU regulations.
• Estimated Timeline for Registration: Approximately 12-18 months, depending on the complexity of the application and regulatory assessments.
• Import Tariff/Duty for HS 30049099: As an EU member, France applies the EU Common External Tariff; pharmaceuticals often benefit from reduced or zero tariffs, but confirmation with French customs is advisable.

• Kenya:
• Drug Regulatory Authority: Pharmacy and Poisons Board (PPB)
• Import Registration Process: Submission of an application to the PPB, including product samples, manufacturing details, and proof of compliance with Good Manufacturing Practices (GMP).
• Estimated Timeline for Registration: Generally 6-9 months, subject to the thoroughness of the application and any required inspections.
• Import Tariff/Duty for HS 30049099: Pharmaceuticals are typically exempt from import duties in Kenya, but it's prudent to confirm with the Kenya Revenue Authority.

• Jamaica:
• Drug Regulatory Authority: Pharmacy Council of Jamaica
• Import Registration Process: Importers must register with the Pharmacy Council, providing detailed product information and evidence of compliance with local regulations.
• Estimated Timeline for Registration: Approximately 4-6 months, depending on the review process and any additional requirements.
• Import Tariff/Duty for HS 30049099: Pharmaceuticals may be subject to import duties; specific rates should be confirmed with Jamaican customs authorities.

It's essential for exporters and importers to stay updated with the respective regulatory authorities, as procedures and tariffs can change over time.

The demand for Terbutaline in importing countries is influenced by several factors:

• Disease Prevalence: Terbutaline is primarily used to treat asthma and other respiratory conditions. Countries with high incidences of these diseases exhibit greater demand for such medications.

• Government Healthcare Programs: National initiatives aimed at improving respiratory health contribute to increased procurement of Terbutaline. For instance, countries implementing universal health coverage expansion often include essential medicines like Terbutaline in their formularies.

• WHO Essential Medicines List Procurement: Terbutaline's inclusion in the WHO Model List of Essential Medicines underscores its importance in treating priority health conditions. This designation encourages countries to procure and stock the medication to meet public health needs.

• Tender-Based Purchasing: Many governments and large healthcare organizations procure medicines through tender processes, ensuring cost-effective and consistent supply. The presence of 131 buyers across 59 countries indicates a robust and diverse market for Terbutaline, with opportunities for suppliers to engage in these procurement processes.

Understanding these demand drivers enables suppliers to align their strategies with the healthcare priorities and procurement mechanisms of importing countries, thereby optimizing market opportunities.

The importation of Terbutaline from India involves various buyer segments, each with distinct purchasing behaviors:

• Distributors: Entities like PRINCE FARMA, LDA (Angola) and PLANET PHARMA (France) function as intermediaries, procuring large quantities to supply to pharmacies, hospitals, and clinics. Their bulk purchasing often leads to economies of scale, and they typically place regular, sizable orders to maintain a steady supply chain.

• Government Procurement Agencies: Organizations such as the STATE PHARMACEUTICAL CORPORATION OF SRI LANKA are responsible for acquiring medicines for public healthcare facilities. Their procurement is characterized by large-volume purchases through formal tender processes, ensuring consistent supply to meet national healthcare demands.

• Retail Chains and Hospital Groups: While specific entities from the top 10 buyers are not explicitly identified in this category, these buyers usually procure Terbutaline to stock their outlets or facilities, ensuring availability for patients. Their orders are typically based on anticipated patient demand and may vary in volume.

• Re-exporters: Companies like ABACUS PHARMA (AFRICA) LTD, operating in Kenya and Uganda, may act as re-exporters, importing Terbutaline to distribute to neighboring countries. Their purchasing patterns are influenced by regional demand and logistical considerations.

• Contract Manufacturers: Not prominently featured among the top buyers, contract manufacturers would typically procure Terbutaline for formulation into finished pharmaceutical products under contract for other companies. Their orders are project-based and depend on contractual agreements.

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.

For the top five importing countries of Terbutaline from India, the import regulations are as follows:

• Angola:
• Drug Regulatory Authority: Ministry of Health (Ministério da Saúde)
• Import Registration Process: Importers must obtain authorization from the Ministry of Health, ensuring compliance with national pharmaceutical standards.
• Estimated Timeline for Registration: Approximately 3-6 months, depending on the completeness of the application and regulatory reviews.
• Import Tariff/Duty for HS 30049099: Specific tariff rates should be confirmed with the Angolan customs authority, as they are subject to periodic revisions.

• Sri Lanka:
• Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA)
• Import Registration Process: Requires submission of a dossier to the NMRA, including product details, manufacturing information, and evidence of compliance with international standards.
• Estimated Timeline for Registration: Typically 6-12 months, contingent on the review process and any additional information requests.
• Import Tariff/Duty for HS 30049099: Pharmaceuticals may be subject to import duties; exact rates should be verified with Sri Lankan customs authorities.

• France:
• Drug Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM)
• Import Registration Process: Medicines must be authorized by the ANSM, requiring comprehensive documentation and adherence to EU regulations.
• Estimated Timeline for Registration: Approximately 12-18 months, depending on the complexity of the application and regulatory assessments.
• Import Tariff/Duty for HS 30049099: As an EU member, France applies the EU Common External Tariff; pharmaceuticals often benefit from reduced or zero tariffs, but confirmation with French customs is advisable.

• Kenya:
• Drug Regulatory Authority: Pharmacy and Poisons Board (PPB)
• Import Registration Process: Submission of an application to the PPB, including product samples, manufacturing details, and proof of compliance with Good Manufacturing Practices (GMP).
• Estimated Timeline for Registration: Generally 6-9 months, subject to the thoroughness of the application and any required inspections.
• Import Tariff/Duty for HS 30049099: Pharmaceuticals are typically exempt from import duties in Kenya, but it's prudent to confirm with the Kenya Revenue Authority.

• Jamaica:
• Drug Regulatory Authority: Pharmacy Council of Jamaica
• Import Registration Process: Importers must register with the Pharmacy Council, providing detailed product information and evidence of compliance with local regulations.
• Estimated Timeline for Registration: Approximately 4-6 months, depending on the review process and any additional requirements.
• Import Tariff/Duty for HS 30049099: Pharmaceuticals may be subject to import duties; specific rates should be confirmed with Jamaican customs authorities.

It's essential for exporters and importers to stay updated with the respective regulatory authorities, as procedures and tariffs can change over time.

The demand for Terbutaline in importing countries is influenced by several factors:

• Disease Prevalence: Terbutaline is primarily used to treat asthma and other respiratory conditions. Countries with high incidences of these diseases exhibit greater demand for such medications.

• Government Healthcare Programs: National initiatives aimed at improving respiratory health contribute to increased procurement of Terbutaline. For instance, countries implementing universal health coverage expansion often include essential medicines like Terbutaline in their formularies.

• WHO Essential Medicines List Procurement: Terbutaline's inclusion in the WHO Model List of Essential Medicines underscores its importance in treating priority health conditions. This designation encourages countries to procure and stock the medication to meet public health needs.

• Tender-Based Purchasing: Many governments and large healthcare organizations procure medicines through tender processes, ensuring cost-effective and consistent supply. The presence of 131 buyers across 59 countries indicates a robust and diverse market for Terbutaline, with opportunities for suppliers to engage in these procurement processes.

Understanding these demand drivers enables suppliers to align their strategies with the healthcare priorities and procurement mechanisms of importing countries, thereby optimizing market opportunities.